Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
03/20/2008 | CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
03/20/2008 | CA2661938A1 Pyrimidines derivatives and their use as kinase inhibitors |
03/19/2008 | EP1900726A1 Heterocyclic thioesters |
03/19/2008 | EP1899329A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
03/19/2008 | EP1899328A1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1h-imidazole-5-carbaldehydes |
03/19/2008 | EP1899327A1 Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) |
03/19/2008 | EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
03/19/2008 | EP1899305A1 Helix 12 directed non-steroidal antiandrogens |
03/19/2008 | EP1899296A1 Histamine-3 receptor antagonists |
03/19/2008 | EP1898917A1 Aminopyrimidines as kinase modulators |
03/19/2008 | EP1898905A2 Hydroisoindoline tachykinin receptor antagonists |
03/19/2008 | EP1824338B1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
03/19/2008 | EP1720544B1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
03/19/2008 | EP1660487B1 Pyrrole compositions useful as inhibitors of c-met |
03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
03/19/2008 | EP1303496B9 Pyrimidine derivatives |
03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
03/19/2008 | CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
03/19/2008 | CN101146796A 3-(indazol-5-yl)-(1,2,4)triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer |
03/19/2008 | CN101146789A Chemical compounds |
03/19/2008 | CN101146773A 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
03/19/2008 | CN101146769A Azolylacylguanidines as beta-secretase inhibitors |
03/19/2008 | CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
03/19/2008 | CN101143862A Ionic compound containing chiral amine-thiourea (urea) and its preparation method and application |
03/18/2008 | USRE40156 Methods for repairing damaged intervertebral discs |
03/18/2008 | US7345085 Indoles having anti-diabetic activity |
03/18/2008 | US7345080 For arachnids and nematodes |
03/18/2008 | US7345078 NF-κB inhibitors and uses thereof |
03/18/2008 | US7345074 Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide |
03/18/2008 | US7345072 As precursors for angiotensin II antagonists; deprotecting the reactive tetrazole nitrogen an anhydrous or concentrated aqueous solution of a hydrohalic acid to obtain the active antagonist |
03/18/2008 | US7345071 Process for the synthesis of Losartan potassium |
03/18/2008 | US7345054 Heterocyclic inhibitors of ERK2 and uses thereof |
03/18/2008 | US7345049 Phenylalanine derivatives |
03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
03/18/2008 | US7345041 Chemical compounds |
03/18/2008 | US7345009 Substituted 4-hetaryl-pyrazolines as pest control agents |
03/18/2008 | CA2287555C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
03/18/2008 | CA2287325C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
03/13/2008 | WO2008030466A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
03/13/2008 | WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
03/13/2008 | WO2008029084A1 Herbicidal compounds and compositions |
03/13/2008 | WO2008028860A1 Benzotriazole kinase modulators |
03/13/2008 | WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
03/13/2008 | WO2008014252A3 Iap inhibitors |
03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
03/13/2008 | WO2007139952A3 Method for the preparation of triazole compounds with hsp90 modulating activity |
03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
03/13/2008 | WO2007135527A3 Benzimidazolyl compounds |
03/13/2008 | WO2007130820A3 Mglur5 modulators i |
03/13/2008 | WO2007127635A3 Diketo-piperazine and piperidine derivatives as antiviral agents |
03/13/2008 | WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
03/13/2008 | US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes |
03/13/2008 | US20080064732 Substituted 4-hetarylpyrazolines |
03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
03/13/2008 | US20080064700 Aryl triazines as LPAAT-beta inhibitors and uses thereof |
03/13/2008 | US20080064698 1-Phenyl and 1-Pyridylpyrazole Derivatives and Their Use as Pesticides |
03/13/2008 | US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
03/13/2008 | US20080064688 Anti-inflammatory medicaments |
03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
03/13/2008 | US20080064684 Sub-type selective serotonin receptor agonists; antidepressants; schizophrenia, Alzheimer's Disease, Parkinson's Disease; alkylation or amidation of the heterocyclylbenzazole with an alkylhalide or acylhalide |
03/13/2008 | US20080064676 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
03/13/2008 | US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents |
03/13/2008 | CA2663100A1 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
03/13/2008 | CA2662998A1 Benzotriazole kinase modulators |
03/13/2008 | CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
03/12/2008 | EP1896465A1 Heterocyclic non-peptide gnrh antagonists |
03/12/2008 | EP1896455A2 Process for the preparation of tetrazolyl compounds |
03/12/2008 | EP1896454A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION |
03/12/2008 | EP1896452A2 N-formyl hydroxylamine compounds |
03/12/2008 | EP1896448A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
03/12/2008 | EP1896412A2 Oxindole derivatives |
03/12/2008 | EP1896029A1 Aminopyrimidines as kinase modulators |
03/12/2008 | EP1896014A2 Chemical compounds |
03/12/2008 | EP1656355B1 Piperazine derivatives and methods of use |
03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
03/12/2008 | CN101142199A [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and N A D P H quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in |
03/12/2008 | CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands |
03/12/2008 | CN101142185A Indoles useful in the treatment of inflammation |
03/12/2008 | CN101141958A Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
03/12/2008 | CN101141956A Use of CRTH2 antagonist compounds in therapy |
03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
03/12/2008 | CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
03/11/2008 | US7342037 Anti-inflammatory medicaments |
03/11/2008 | US7342030 Indole derivatives |
03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |